Description
APRIL: APRIL Drives Plasma Cell Survival and Humoral Immune Homeostasis.
- Gene Information: APRIL (TNFSF13) encodes A Proliferation-Inducing Ligand, a transmembrane and soluble cytokine located on human chromosome 17p13.1 that serves as a critical regulator of plasma cell survival and B-cell differentiation.
- Protein Expression: Expressed primarily by innate immune cells including monocytes, macrophages, dendritic cells, and neutrophils, APRIL undergoes intracellular cleavage by furin convertase to be released as a biologically active soluble homotrimer.
- Signaling Pathway: Binding high-affinity receptors BCMA and TACI on plasma cells and mature B cells activates classical and non-canonical NF-$\kappa$B and MAP kinase pathways, upregulating anti-apoptotic proteins like Bcl-2 to sustain cell survival.
- Therapeutic Inhibition: Targeting APRIL with neutralizing monoclonal antibodies or soluble decoy receptors selectively depletes pathogenic antibody-producing plasma cells, offering targeted therapeutic approaches for IgA nephropathy, multiple myeloma, and systemic lupus erythematosus.
TWEAK: TWEAK Activates Fn14 to Drive Inflammation and Remodeling.
- Gene Information: TWEAK (TNFSF12) encodes TNF-like weak inducer of apoptosis, a multifunctional cytokine located on human chromosome 17p13.1 that regulates cell survival, proliferation, tissue regeneration, and pro-inflammatory responses.
- Protein Expression: Expressed as membrane-bound and soluble forms primarily by monocytes, macrophages, dendritic cells, and T lymphocytes, TWEAK expression is significantly upregulated at sites of acute or chronic tissue injury.
- Signaling Pathway: Binding specifically to its sole receptor Fn14, TWEAK recruits TRAF adaptor proteins to activate canonical and non-canonical NF-κB, MAPK, and Akt pathways, driving pro-inflammatory cytokine expression and cellular responses.
- Therapeutic Inhibition: Targeting TWEAK or Fn14 with neutralizing monoclonal antibodies attenuates pathological inflammation, tissue fibrosis, and cell death, serving as a potential therapeutic strategy for autoimmune diseases, kidney injury, and ischemic stroke.
Human TWEAK and APRIL mRNA Expression Analysis in TWEAK/APRIL Humanized Rats
- Mouse Tweak and April mRNA were detected in lung and liver of wild-type SD rats.
- Human TWEAK and APRIL mRNA were detected in lung and liver of homozygous TWEAK/APRIL humanized Rats, but not in wild-type SD rats.
Species specific analysis of TWEAK and APRIL gene expression in wild-type SD rats and homozygous TWEAK/APRIL humanized rats by RT-PCR. Lung and liver RNA were isolated from wild-type SD rats (+/+) and homozygous B-hTWEAK/hAPRIL rats (H/H), and then cDNA libraries were synthesized by reverse transcription, followed by PCR with rat Tweak primers, human TWEAK primers, rat April primers, and human APRIL primers.
Protein Expression Profiles of TWEAK in TWEAK/APRIL Humanized Rats
- TWEAK was detectable in spleen, liver, kidney, lung, colon and heart of homozygous TWEAK/APRIL humanized rats and wild-type SD rats due to the cross-reactivity of anti-TWEAK antibody .
Strain specific TWEAK expression analysis in wild-type SD rats and homozygous TWEAK/APRIL humanized rats by western blot. Various tissue lysates were collected from wild-type SD rats (+/+) and homozygous B-hTWEAK/APRIL rats (H/H). Protein expression was analyzed with anti-TWEAK antibody (thermo fisher, PA5-96379) by western blot.
Human APRIL Protein Expression Analysis in Serum of TWEAK/APRIL Humanized Rats
- Human APRIL was detected in serum of homozygous TWEAK/APRIL humanized rats, but not in wild-type SD rats.
Strain specific APRIL expression analysis in wild-type SD rats and homozygous TWEAK/APRIL humanized rats by ELISA. Serum was collected from wild-type SD rats and homozygous B-hTWEAK/hAPRIL rats (female, 14-week-old, n = 3). Expression level of human APRIL were analyzed by ELISA (anti-human APRIL kit: thermo fisher, BMS2008). Values are expressed as mean ± SEM. ND: not detectable.
* When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-hTWEAK/hAPRIL rats] (Cat# 113156) was purchased from Biocytogen.